Etoposide에 대한 사람구강편평상피암종세포의 세포자멸사 반응

Apoptotic Response of Human Oral Squamous Carcinoma Cells to Etoposide

  • 김규천 (부산대학교 치과대학 및 구강생물공학연구소 구강해부학교실) ;
  • 이경덕 (부산대학교 치과대학 및 구강생물공학연구소 구강해부학교실) ;
  • 박재현 (부산대학교 치과대학 및 구강생물공학연구소 구강해부학교실) ;
  • 김덕한 (부산대학교 치과대학 및 구강생물공학연구소 구강해부학교실) ;
  • 박정길 (부산대학교 치과대학 및 구강생물공학연구소 구강보존과학교실) ;
  • 박준상 (부산대학교 치과대학 및 구강생물공학연구소 구강내과학교실) ;
  • 박봉수 (부산대학교 치과대학 및 구강생물공학연구소 구강해부학교실)
  • Kim, Gyoo-Cheon (Dept. of Oral Anatomy, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Lee, Kyoung-Duk (Dept. of Oral Anatomy, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Park, Jae-Hyun (Dept. of Oral Anatomy, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Kim, Duk-Han (Dept. of Oral Anatomy, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Park, Jeong-Kil (Dept. of Oral Conserve dentistry, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Park, June-Sang (Dept. of Oral Medicine, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University) ;
  • Park, Bong-Soo (Dept. of Oral Anatomy, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University)
  • 발행 : 2005.06.30

초록

항암제의 연구는 화학물질에 민감한 암세포를 죽음에 이르게 하는 세포자멸사와 같은 다양한 세포기능에 초점을 맞추어 왔다. 그러나 약물이 유도한 세포의 죽음에 있어서 핵심적인 분자적 기작은 아직 잘 이해되지 않고 있다. Etoposide는 폐암과 고환암에 사용되는 항암제로서, 본 연구는 etoposide가 사람구강편평상피암종세포(OSC9)에도 세포독성효과와 세포자멸사를 일으키는지를 알아보기 위해 실행하였다. 이 실험에서 etoposide는 농도와 시간 의존적으로 OSC9 세포의 생존율를 현저하게 저해시켰다. TUNEL 염색과 Hoechst 염색을 이용한 핵의 형태학적 관찰에서는 etoposide에 의해 핵이 응축되고 분절되었다. p53의 발현은 48 시간에 증가했으며, etoposide 처리로 인해 caspase-3의 활성을 관찰할 수 있었으며, 그 기질에 해당되는 PARP 단백질은 116-kDa과 89-kDa으로 분절되었다. 위의 결과들은 OSC9 세포에서 etoposide가 유도한 세포자멸사는 caspase-3의 활성과 관련됨을 설명하고 있다.

참고문헌

  1. Golstein P: Controlling cell death. Science 275(5303) :1081-1082, 1997 https://doi.org/10.1126/science.275.5303.1081
  2. Enari, M., Sakahira, H., Yokoyama, H. et al. : A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391(6662) :43-50, 1998 https://doi.org/10.1038/34112
  3. Wagner, A.J., Kokontis, J.M. and Hay, N.: Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 8 :2817-2830, 1994 https://doi.org/10.1101/gad.8.23.2817
  4. Steller, H.: Mechanisms and genes of cellular suicide. Science 267(5203) : 1445-1449, 1995 https://doi.org/10.1126/science.7878463
  5. Burden, D.A., Kingma, P.S., Froelich-Ammon, S.J. et al. : Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem 271(46) : 29238-29244, 1996 https://doi.org/10.1074/jbc.271.46.29238
  6. Ramirez, C.D., Sleiman, R.J., Catchpoole, D.R. and Stewart, B.W.: Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells. Cell Death Differ 7(6): 548-555, 2000 https://doi.org/10.1038/sj.cdd.4400686
  7. Schulze-Osthoff, K., Walczak, H., Droge, W. and Krammer, P.H.: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127 : 15-20, 1994 https://doi.org/10.1083/jcb.127.1.15
  8. Soldani, C., Lazze, M.C., Bottone, M.G. et al. : Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where? Exp Cell Res 269(2) :193-201, 2001 https://doi.org/10.1006/excr.2001.5293
  9. Thornberry, N.A., Rosen, A. and Nicholson, D.W.: Control of apoptosis by proteases, in Apoptosis (Kaufmann SH eds). Adv Pharmacol 44 : 155-177, 1997
  10. Ko, L.J. and Prives, C.: p53: puzzle and paradigm. Genes Dev 10 : 1054-1072, 1996 https://doi.org/10.1101/gad.10.9.1054
  11. Fisher, D.E.: Apoptosis in cancer therapy: crossing the threshold. Cell 78(4) : 539-542, 1994 https://doi.org/10.1016/0092-8674(94)90518-5
  12. Clarke, A.R., Purdie, C.A., Harrison, D.J. et al. : Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362(6423) : 849-852, 1993 https://doi.org/10.1038/362849a0
  13. Attardi, L.D., Reczek, E.E., Cosmas, C. et al. : PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14 : 704-718, 2000
  14. Yin, Y., Terauchi, Y., Solomon, G.G. et al. : Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391 : 707-710, 1998 https://doi.org/10.1038/35648
  15. Orth, K., O'Rourke, K., Salvesen, G.S., and Dixit, V.M.: Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J Biol Chem 271(35) :20977-20980, 1996 https://doi.org/10.1074/jbc.271.35.20977
  16. Wyllie, A.H., Kerr, J.F., and Currie, A.R.: Cell death: the significance of apoptosis. Int Rev Cytol 68 :251-306, 1980 https://doi.org/10.1016/S0074-7696(08)62312-8
  17. Nicholson, D.W. and Thornberry, N.A.: Caspases: killer proteases. Trends Biochem Sci 22 : 299-306, 1997 https://doi.org/10.1016/S0968-0004(97)01085-2
  18. Ucker, D.S., Obermiller, P.S., Eckhart, W. et al. : Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol 12 : 3060-3069, 1992 https://doi.org/10.1128/MCB.12.7.3060
  19. Linke, S.P., Clarkin, K.C., Di, Leonardo, A., Tsou, A. and Wahl, G.M.: A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 10 : 934-947, 1996 https://doi.org/10.1101/gad.10.8.934
  20. Tolis, C., Peters, G.J., Ferreira, C.G., Pinedo, H.M. and Giaccone, G.: Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer 35(5) : 796-807, 1999 https://doi.org/10.1016/S0959-8049(98)00425-0
  21. Harris, C.C.: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88(20) : 1442-1455, 1996 https://doi.org/10.1093/jnci/88.20.1442
  22. Yuan, J.: Evolutionary conservation of a genetic pathway of programmed cell death. J Cell Biochem 60: 4-11, 1996 https://doi.org/10.1002/(SICI)1097-4644(19960101)60:1<4::AID-JCB2>3.0.CO;2-1
  23. Sakahira, H., Enari, M. and Nagata, S.: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391(6662) :96-99, 1998 https://doi.org/10.1038/34214
  24. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E.: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74(6) : 957-967, 1993 https://doi.org/10.1016/0092-8674(93)90719-7
  25. Schmitt, C.A. and Lowe, S.W. : Apoptosis and Therapy. J Pathol 187 : 127-137, 1999 https://doi.org/10.1002/(SICI)1096-9896(199901)187:1<127::AID-PATH251>3.0.CO;2-T
  26. Williams, G.T. : Programmed cell death: apoptosis and oncogenesis. Cell 65 : 1097-1098, 1991 https://doi.org/10.1016/0092-8674(91)90002-G
  27. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J.: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 :88-91, 1996 https://doi.org/10.1038/379088a0
  28. Levine, A.J.: The tumor suppressor genes. Annu Rev Biochem 62 : 623-651, 1993 https://doi.org/10.1146/annurev.bi.62.070193.003203